News from the healthcare data industry
Baker McKenzie United Kingdom February 2 2022 NICE has produced a single guidance development manual, which describes how NICE conducts itself with each step and stage in its evaluation (NICE’s processes) and...
WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences solutions, recognizes the vital importance of the Voice of the Patient across the entire product lifecycle. Trinity’s patient focus...
SOLANA BEACH, Calif. and CHICAGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company primarily focused on treatments for gastrointestinal (GI) diseases, and EVERSANA...
HAYWARD, Calif., Feb. 1, 2022 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced...
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these...
CHICAGO, Feb. 01, 2022 (GLOBE NEWSWIRE) — Q-Centrix, the largest exclusive provider of clinical data management solutions to health systems, today announced a partnership with Datavant, the leader in helping organizations securely...
During his talk at the recent J.P. Morgan Healthcare Conference, Mayo Clinic CEO Gianrico Farrugia laid out a sweeping vision for technology transformation, driven largely by private sector upstarts that...
Scott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment February 02, 2022 08:00 AM...
The Chan Zuckerberg Initiative’s Rare as One Network will gain access to Komodo’s Healthcare Map to advance research and better understand care gapsJanuary 31, 2022 09:11 AM Eastern Standard Time...
January 27, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics and Providence Health Plan today announced a collaboration to conduct a Phase 3 study of Cognito’s breakthrough, non-invasive...